177 related articles for article (PubMed ID: 2598467)
21. Branched-chain ketoacid dehydrogenase activity and growth of normal and mutant human fibroblasts: the effect of branched-chain amino acid concentration in culture medium.
Danner DJ; Priest JH
Biochem Genet; 1983 Oct; 21(9-10):895-905. PubMed ID: 6661177
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
[TBL] [Abstract][Full Text] [Related]
23. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
24. Degradation of branched-chain amino acids and their derived 2-oxo acids and fatty acids in human and rat heart and skeletal muscle.
Wagenmakers AJ; Veerkamp JH
Biochem Med; 1982 Aug; 28(1):16-31. PubMed ID: 6816224
[No Abstract] [Full Text] [Related]
25. Transamination and oxidation of leucine and valine in rat adipose tissue.
Frick GP; Blinder L; Goodman HM
J Biol Chem; 1988 Mar; 263(7):3245-9. PubMed ID: 3125177
[TBL] [Abstract][Full Text] [Related]
26. Effects of perfusate leucine concentration on the metabolism of valine by the isolated rat hindquarter.
Zapalowski C; Miller RH; Dixon JL; Harper AE
Metabolism; 1984 Oct; 33(10):922-7. PubMed ID: 6482735
[TBL] [Abstract][Full Text] [Related]
27. Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.
Dancis J; Hutzler J; Cox RP
Am J Hum Genet; 1977 May; 29(3):272-9. PubMed ID: 868873
[TBL] [Abstract][Full Text] [Related]
28. A distinct variant of intermediate maple syrup urine disease.
Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
[TBL] [Abstract][Full Text] [Related]
29. [Maple syrup urine disease: molecular pathology of the branched chain alpha-keto acid dehydrogenase complex].
Nobukuni Y; Mitsubuchi H; Indo Y; Endo F; Matsuda I
Seikagaku; 1992 Feb; 64(2):67-82. PubMed ID: 1593184
[No Abstract] [Full Text] [Related]
30. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.
Patel MS
Biochem J; 1974 Oct; 144(1):91-7. PubMed ID: 4462577
[TBL] [Abstract][Full Text] [Related]
31. Activation of branched-chain alpha-ketoacid dehydrogenase complex by alpha-chloroisocaproate in normal and enzyme-deficient fibroblasts.
Toshima K; Kuroda Y; Yokota I; Naito E; Ito M; Watanabe T; Takeda E; Miyao M
Clin Chim Acta; 1985 Apr; 147(2):103-8. PubMed ID: 3987057
[TBL] [Abstract][Full Text] [Related]
32. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
Skaper SD; Molden DP; Seegmiller JE
Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
[TBL] [Abstract][Full Text] [Related]
33. Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.
Indo Y; Kitano A; Endo F; Akaboshi I; Matsuda I
J Clin Invest; 1987 Jul; 80(1):63-70. PubMed ID: 3597778
[TBL] [Abstract][Full Text] [Related]
34. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
[TBL] [Abstract][Full Text] [Related]
35. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
36. [Gene analysis of maple syrup urine disease (MSUD)].
Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
[TBL] [Abstract][Full Text] [Related]
37. Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.
Chuang DT; Ku LS; Kerr DS; Cox RP
Am J Hum Genet; 1982 May; 34(3):416-24. PubMed ID: 7081220
[TBL] [Abstract][Full Text] [Related]
38. Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo.
Aftring RP; Block KP; Buse MG
Am J Physiol; 1986 May; 250(5 Pt 1):E599-604. PubMed ID: 3706523
[TBL] [Abstract][Full Text] [Related]
39. A structural abnormality of E1 component of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease.
Indo Y; Kitano A; Akaboshi I; Endo F; Matsuda I
J Inherit Metab Dis; 1987; 10(3):281-3. PubMed ID: 3123794
[No Abstract] [Full Text] [Related]
40. Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex.
Fisher CW; Chuang JL; Griffin TA; Lau KS; Cox RP; Chuang DT
J Biol Chem; 1989 Feb; 264(6):3448-53. PubMed ID: 2914958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
